Annual Cash & Cash Equivalents
$14.69 M
+$5.09 M+53.02%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual cash & cash equivalents is $14.69 million, with the most recent change of +$5.09 million (+53.02%) on December 31, 2023.
- During the last 3 years, CAPR annual cash & cash equivalents has fallen by -$17.97 million (-55.01%).
- CAPR annual cash & cash equivalents is now -57.88% below its all-time high of $34.89 million, reached on December 31, 2021.
Performance
CAPR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$68.38 M
+$57.69 M+539.73%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly cash and cash equivalents is $68.38 million, with the most recent change of +$57.69 million (+539.73%) on September 30, 2024.
- Over the past year, CAPR quarterly cash and cash equivalents has increased by +$57.69 million (+539.73%).
- CAPR quarterly cash and cash equivalents is now at all-time high.
Performance
CAPR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CAPR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.0% | +539.7% |
| 3 y3 years | -55.0% | +612.0% |
| 5 y5 years | +245.0% | +612.0% |
CAPR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.9% | +53.0% | at high | +1000.3% |
| 5 y | 5-year | -57.9% | +276.9% | at high | +1653.6% |
| alltime | all time | -57.9% | -100.0% | at high | -100.0% |
Capricor Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $68.38 M(+539.7%) |
| Jun 2024 | - | $10.69 M(+72.0%) |
| Mar 2024 | - | $6.21 M(-57.7%) |
| Dec 2023 | $14.69 M(+53.0%) | $14.69 M(+63.6%) |
| Sep 2023 | - | $8.98 M(-8.7%) |
| Jun 2023 | - | $9.84 M(-7.2%) |
| Mar 2023 | - | $10.61 M(+10.4%) |
| Dec 2022 | $9.60 M(-72.5%) | $9.60 M(+14.1%) |
| Sep 2022 | - | $8.41 M(-48.7%) |
| Jun 2022 | - | $16.39 M(-71.9%) |
| Mar 2022 | - | $58.33 M(+67.2%) |
| Dec 2021 | $34.89 M(+6.8%) | $34.89 M(-14.6%) |
| Sep 2021 | - | $40.84 M(+7.3%) |
| Jun 2021 | - | $38.08 M(-9.1%) |
| Mar 2021 | - | $41.88 M(+28.2%) |
| Dec 2020 | $32.67 M(+737.7%) | $32.67 M(-7.5%) |
| Sep 2020 | - | $35.30 M(-2.6%) |
| Jun 2020 | - | $36.25 M(+174.3%) |
| Mar 2020 | - | $13.22 M(+239.0%) |
| Dec 2019 | $3.90 M(-8.5%) | $3.90 M(-42.9%) |
| Sep 2019 | - | $6.83 M(+15.9%) |
| Jun 2019 | - | $5.89 M(-17.8%) |
| Mar 2019 | - | $7.17 M(+68.3%) |
| Dec 2018 | $4.26 M(-30.6%) | $4.26 M(-2.7%) |
| Sep 2018 | - | $4.38 M(-30.9%) |
| Jun 2018 | - | $6.34 M(-11.6%) |
| Mar 2018 | - | $7.17 M(+16.8%) |
| Dec 2017 | $6.14 M(+91.6%) | $6.14 M(-31.0%) |
| Sep 2017 | - | $8.90 M(+7.7%) |
| Jun 2017 | - | $8.26 M(+200.3%) |
| Mar 2017 | - | $2.75 M(-14.2%) |
| Dec 2016 | $3.20 M(-42.5%) | $3.20 M(-82.2%) |
| Sep 2016 | - | $18.02 M(+103.6%) |
| Jun 2016 | - | $8.85 M(-24.8%) |
| Mar 2016 | - | $11.77 M(+111.3%) |
| Dec 2015 | $5.57 M(-30.7%) | $5.57 M(+32.0%) |
| Sep 2015 | - | $4.22 M(-16.3%) |
| Jun 2015 | - | $5.04 M(-27.4%) |
| Mar 2015 | - | $6.94 M(-13.6%) |
| Dec 2014 | $8.03 M(+364.6%) | $8.03 M(-18.1%) |
| Sep 2014 | - | $9.81 M(-15.3%) |
| Jun 2014 | - | $11.58 M(-10.8%) |
| Mar 2014 | - | $12.98 M(+650.5%) |
| Dec 2013 | $1.73 M | $1.73 M(+2335.9%) |
| Sep 2013 | - | $71.00 K(-69.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $229.20 K(-19.6%) |
| Mar 2013 | - | $285.00 K(+67.5%) |
| Dec 2012 | $170.10 K(-83.6%) | $170.10 K(-39.8%) |
| Sep 2012 | - | $282.50 K(-63.7%) |
| Jun 2012 | - | $777.20 K(+78.4%) |
| Mar 2012 | - | $435.70 K(-58.1%) |
| Dec 2011 | $1.04 M(-69.2%) | $1.04 M(-60.1%) |
| Sep 2011 | - | $2.61 M(-20.0%) |
| Jun 2011 | - | $3.26 M(+53.5%) |
| Mar 2011 | - | $2.12 M(-37.1%) |
| Dec 2010 | $3.38 M(+6.4%) | $3.38 M(-23.8%) |
| Sep 2010 | - | $4.44 M(-20.3%) |
| Jun 2010 | - | $5.56 M(+176.3%) |
| Mar 2010 | - | $2.01 M(-36.6%) |
| Dec 2009 | $3.18 M(-42.3%) | $3.18 M(-24.8%) |
| Sep 2009 | - | $4.22 M(+138.6%) |
| Jun 2009 | - | $1.77 M(-50.9%) |
| Mar 2009 | - | $3.61 M(-34.4%) |
| Dec 2008 | $5.50 M(-66.1%) | $5.50 M(-25.3%) |
| Sep 2008 | - | $7.36 M(-28.8%) |
| Jun 2008 | - | $10.35 M(-24.2%) |
| Mar 2008 | - | $13.66 M(-15.9%) |
| Dec 2007 | $16.23 M(>+9900.0%) | $16.23 M(-10.0%) |
| Sep 2007 | - | $18.04 M(>+9900.0%) |
| Sep 2006 | - | $300.00(-40.0%) |
| Jun 2006 | - | $500.00(+25.0%) |
| Mar 2006 | - | $400.00(+33.3%) |
| Dec 2005 | $300.00(-50.0%) | $300.00(-90.3%) |
| Sep 2005 | - | $3100.00(+3000.0%) |
| Jun 2005 | - | $100.00(-96.4%) |
| Mar 2005 | - | $2800.00(+366.7%) |
| Dec 2004 | $600.00(-45.5%) | $600.00(-33.3%) |
| Sep 2004 | - | $900.00(-74.3%) |
| Jun 2004 | - | $3500.00(-59.8%) |
| Mar 2004 | - | $8700.00(+690.9%) |
| Dec 2003 | $1100.00(>+9900.0%) | $1100.00(>+9900.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2002 | - | $100.00(0.0%) |
| Jun 2002 | - | $100.00(-98.4%) |
| Mar 2002 | - | $6100.00(+2950.0%) |
| Dec 2001 | $200.00(-98.5%) | $200.00 |
| Dec 2000 | $13.20 K(>+9900.0%) | - |
| Dec 1999 | $0.00 | - |
FAQ
- What is Capricor Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Capricor Therapeutics?
- What is Capricor Therapeutics annual cash & cash equivalents year-on-year change?
- What is Capricor Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Capricor Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CAPR is $14.69 M
What is the all time high annual cash & cash equivalents for Capricor Therapeutics?
Capricor Therapeutics all-time high annual cash & cash equivalents is $34.89 M
What is Capricor Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CAPR annual cash & cash equivalents has changed by +$5.09 M (+53.02%)
What is Capricor Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CAPR is $68.38 M
What is the all time high quarterly cash and cash equivalents for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly cash and cash equivalents is $68.38 M
What is Capricor Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CAPR quarterly cash and cash equivalents has changed by +$57.69 M (+539.73%)